Pharmafile Logo
Pharmafocus logo
Advanced Search

Allergan

Showing 15 posts of 142 posts found.

allergan

Allergan settles gender discrimination case for $4m

October 11, 2017
Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …

News
shire_image

Shire takes fight to Allergan over dry-eye drug

October 4, 2017
Research and Development Allergan, Restasis, Shire, biotech, drugs, pharma, pharmaceutical

It’s not long since Allergan was in the headlines over its dry-eye drug, Restasis, after an eye-catching attempt to avoid …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten

It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …

News
tessa_hilado-web-aug2017-allergan

Allergan’s Executive VP and Chief Financial Officer steps down

September 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, appointment

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …

Appointment
allergan

Allergan posts disappointing data in NASH

September 25, 2017
Research and Development, Sales and Marketing Allergan, biotech, drugs, nash, pharma, pharmaceutical

It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …

News
shutterstock_138095450

New data shows pharma has not cut back on controversial payments to physicians

July 6, 2017
Medical Communications, Sales and Marketing Allergan, Biogen, Celgene, Sanofi, Valeant

Despite increasing controversy arising over the years due to the questionable relationship between physicians and pharma and the money which …

News
shutterstock_212432119

Allergan and Novartis join forces to develop NASH combo therapy

April 18, 2017
Manufacturing and Production, Research and Development Allergan, Novartis, nash

Allergan and Novartis have announced a new partnership to conduct a clinical trial in the treatment area of non-alcoholic steatohepatitis …

News
sanjiv

Relay Therapeutics appoints Allergan CSO to CEO position

April 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Relay

Relay Therapeutics, a biotech firm launched in September 2016, has announced that Sanjiv K. Patel will be its CEO. Patel …

Appointment
allergan

Allergan set to bolster ‘medical aesthetics’ unit with $2.5 billion Zeltiq deal

February 13, 2017
Manufacturing and Production, Sales and Marketing Allergan, FDA, Zeltiq

Allergan, the owner of Botox, has expanded its stake in the ‘medical aesthetics’ business by acquiring Zeltiq Aesthetics. Zeltiq has …

News
allerganlogo

Allergan successfully completes $2.9bn LifeCell acquisition

February 2, 2017
Business Services, Sales and Marketing Allergan, LifeCell

The acquisition of regenerative medicine firm LifeCell by Allergan for $2.9 billion announced back in December has been completely successfully, …

News
allergan

Allergan fined £15m over failure to disclose merger discussions

January 19, 2017
Sales and Marketing Allergan, SEC

Allergan has been fined $15 million by the Security and Exchange Commission (SEC) after committing disclosure violations during merger talks …

News
allergan

Allergan shells out $2.9bn for regenerative medicine unit LifeCell

December 21, 2016
Research and Development, Sales and Marketing Allergan, LifeCell, acquisition

Allergan has agreed a deal to acquire Acelity-owned regenerative medicine unit LifeCell for $2.9 billion in cash, assimilating its portfolio …

News

Teva to shut down Maltese plant, axe 210 jobs

November 30, 2016
Manufacturing and Production, Research and Development Actavis Generics, Allergan, Malta, Teva

Teva is set to axe 210 jobs and shut down a production plant in Malta in an effort to cut …

News
adriane_brown

Allergan appoints Adriane M. Brown to board of directors

November 14, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan

Allergan announced that Adriana M. Brown will join its board of directors on February 2017. Adriana Brown is currently the …

Appointment
allergan

Allergan in $200 million purchase of biopharmaceutical

October 28, 2016
Medical Communications Allergan, Motus Therapeutics, Rythm Holding, Teva

Allergan will acquire Motus Therapeautics, a biopharmaceutical company that specialises in developing treatments for gastroparesis. It is another acquisition that …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023